Zobrazeno 1 - 10
of 221
pro vyhledávání: '"Y, Lorcy"'
Autor:
Y. Lorcy, C. Josseaume
Publikováno v:
Annales d'Endocrinologie. 69:S33-S36
Resume Les hormones thyroidiennes principalement la 3, 5, 3’-I-thyronine (T3)] interviennent au niveau du cholesterol et du metabolisme des lipoproteines mais leur utilisation en tant qu’agent hypolipemiant est limitee par leurs effets cardiaques
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8947052efea82aaeb385c27d98bfaa4
https://doi.org/10.1016/s0003-4266(08)73966-0
https://doi.org/10.1016/s0003-4266(08)73966-0
Autor:
Y. Lorcy, C. Josseaume
Publikováno v:
Annales d'Endocrinologie. 69:S29-S32
Resume La prise en charge de l’ophtalmopathie basedowienne (OB) severe represente un defi difficile et les resultats sont decevants dans un tiers des cas. Les glucocorticoides, la radiotherapie orbitaire ou la combinaison des deux sont, en raison d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c65d338121357156d331266782644f8f
https://doi.org/10.1016/s0003-4266(08)73965-9
https://doi.org/10.1016/s0003-4266(08)73965-9
Publikováno v:
Annales d'Endocrinologie. 68:186-190
There is few published series dealing on the long-term outcome of the adult-onset craniopharyngiomas. We report the long term clinical, tomodensitometric and MRI data outcome of 35 (23 woman and 12 men) consecutive adult-onset cured for craniopharyng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aa5404ee85ab987670841faca55dc86
https://doi.org/10.1016/j.ando.2007.04.001
https://doi.org/10.1016/j.ando.2007.04.001
Publikováno v:
EMC - Cardiologie-Angéiologie. 2:127-135
Resume Les hormones thyroidiennes agissent directement sur le cœur et le systeme circulatoire, ceci par une majoration de l’effet inotrope myocardique, du rythme cardiaque et une vasodilatation peripherique entrainant une augmentation du debit car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add6ab2540ba41bc832fd457d039a55a
https://doi.org/10.1016/j.emcaa.2005.01.001
https://doi.org/10.1016/j.emcaa.2005.01.001
Autor:
Y. Lorcy
Publikováno v:
Annales d'Endocrinologie. 66:18-23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cc9aefb813a30439e96602343508497
https://doi.org/10.1016/s0003-4266(05)81683-x
https://doi.org/10.1016/s0003-4266(05)81683-x
Autor:
Y. Lorcy
Publikováno v:
Annales d'Endocrinologie. 66:55-58
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2b9b8e66f9f06811d1f9405a4c4be72
https://doi.org/10.1016/s0003-4266(05)81695-6
https://doi.org/10.1016/s0003-4266(05)81695-6
Autor:
Susan M. Webb, B. Charbonnel, Christiane Ajzenberg, Brigitte Delemer, Werner A. Scherbaum, R Santen, F Jockenhoevel, Ph. Caron, L Foubert, H Prestele, Y. Bachelot, C. Cortet, Pedro J. Benito, Varela C, V Boerlin, Jean-Marc Kuhn, Patrick Roger, J Leclere, E. Torres, F Escobar-Jiménez, Sonia Gaztambide, J Bringer, L Perlemuter, Vincent Rohmer, Geneviève Sassolas, Y Lorcy, F Villamil, Philippe Chanson, Jochen Schopohl
Publikováno v:
Clinical Endocrinology. 53:577-586
BACKGROUND AND OBJECTIVE The most effective option for the medical treatment of patients with acromegaly is the use of somatostatin analogues. Long-acting depot formulations for intramuscular injection of two somatostatin analogues have recently beco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91d8e937804a79b43465b968266d93ce
https://doi.org/10.1046/j.1365-2265.2000.01134.x
https://doi.org/10.1046/j.1365-2265.2000.01134.x
Publikováno v:
Pituitary. 3:193-197
Aim: Several studies have demonstrated the efficacy of octreotide LAR administered intramuscularly at 4-week intervals in the treatment of acromegaly. In contrast, few data are available on the time course of GH and IGF-1 plasma levels following octr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcbccec2c71ad0ef89a65134de95f023
https://doi.org/10.1023/a:1011416112730
https://doi.org/10.1023/a:1011416112730
Autor:
Y Lorcy, Catherine Massart, I. Guilhem, Loïc Campion, D Maugendre, A. Gatel, J. Y. Herry, J. Lescouarch, H Allannic
Publikováno v:
Clinical Endocrinology. 50:127-132
OBJECTIVE Although antithyroid drugs (ATD) are widely used in the treatment of Graves' disease, management protocols, especially treatment duration, remain a subject of debate. The rate of relapse after short-term regimens of less than 6 months with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d537dab919ce17339de5301e052dce6
https://doi.org/10.1046/j.1365-2265.1999.00629.x
https://doi.org/10.1046/j.1365-2265.1999.00629.x
Autor:
C, Josseaume, Y, Lorcy
Publikováno v:
Annales d'endocrinologie. 69
Treatment of severe Graves'ophtalmopathy (GO) is a complex therapeutic challenge and spite any efforts, about one third of patients are disappointed with the outcome of treatment. Intravenous glucocorticoids (GCIV), orbital radiotherapy, or the combi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e56544b422fc07c8f56e09864fae2ea1
https://pubmed.ncbi.nlm.nih.gov/18954856
https://pubmed.ncbi.nlm.nih.gov/18954856